peoplePerson
Kellie N. Smith
Developed the MANAFEST assay to track the tumour-specific T cells that immunotherapy awakens.
Immunologist who built functional assays for mutation-associated neoantigen-specific T cells and applies them to neoadjuvant immunotherapy trials.
Role
Associate Professor of Oncology; Bloomberg~Kimmel Institute
Specialisms
T-cell immunologyNeoantigen-specific T cellsMANAFEST assay
Profiles
| Title | Journal | Year |
|---|---|---|
| MANAFEST: a functional assay to detect and track mutation-associated neoantigen-specific T cells | Cancer Immunology Research | 2018 |